Prognostic value of lactate dehydrogenase to albumin ratio (LAR) in patients with resectable esophageal squamous cell carcinoma

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: Cancer J Clin. 2015;65(1):5–29. doi:10.3322/caac.2125425559415
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA: Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Lin Y, Totsuka Y, He Y, et al. Epidemiology of esophageal cancer in Japan and China. J Epidemiol. 2013;23(4):233–242. doi:10.2188/jea.je2012016223629646
   PubMed Web of Science ®Google Scholar
• Shen J, Chen Z, Zhuang Q, et al. Prognostic value of serum lactate dehydrogenase in renal cell carcinoma: a systematic review and meta-analysis. PLoS One. 2016;11(11):e0166482. doi:10.1371/journal.pone.016648227861542
   PubMed Web of Science ®Google Scholar
• Brown JE, Cook RJ, Lipton A, Coleman RE. Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer: a retrospective analysis in bisphosphonate treated patients. Clin Cancer Res. 2012;18(22):6348–6355. doi:10.1158/1078-0432.CCR-12-139722952345
   PubMed Web of Science ®Google Scholar
• Gong T, Liu J, Jiang J, et al. The role of lactate deshydrogenase levels on non-small cell lung cancer prognosis: a meta-analysis. Cell Mol Biol. 2019;65(1):89–93. doi:10.14715/cmb/2019.65.1.16
   PubMed Web of Science ®Google Scholar
• Yu SL, Xu LT, Qi Q, et al. Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy. Sci Rep. 2017;7:45194. doi:10.1038/srep4519428345594
   PubMed Web of Science ®Google Scholar
• Wei Z, Zeng X, Xu J, Duan X, Xie Y. Prognostic value of pretreatment serum levels of lactate dehydrogenase in nonmetastatic nasopharyngeal carcinoma: singlesite analysis of 601 patients in a highly endemic area. Onco Targets Ther. 2014;7:739–749. doi:10.2147/OTT.S5980424868167
   PubMed Web of Science ®Google Scholar
• Wei XL, Zhang DS, He MM, et al. The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma. Tumour Biol. 2016;37(2):1879–1887. doi:10.1007/s13277-015-3851-y26323257
   PubMedGoogle Scholar
• Zhang P, Xi M, Li QQ, et al. The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy. J Cancer. 2014;5(8):689–695. doi:10.7150/jca.956925258650
   PubMed Web of Science ®Google Scholar
• Huang H, Wang XP, Li XH, et al. Prognostic value of pretreatment alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma. BMC Cancer. 2017;17:544. doi:10.1186/s12885-017-3523-y28806937
   PubMed Web of Science ®Google Scholar
• Gao Q, Qiu JC, Huang XH, et al. The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy. Cancer Cell Int. 2018;18:153. doi:10.1186/s12935-018-0648-230305803
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Miyata H, Sugimura K, et al. Prognostic significance of sarcopenia and systemic inflammatory response in patients with esophageal cancer. Anticancer Res. 2019;39(1):449–458. doi:10.21873/anticanres.1313330591494
   PubMed Web of Science ®Google Scholar
• Miyata H, Yamasaki M, Kurokawa Y, et al. Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer. Exp Ther Med. 2011;2(5):879–885. doi:10.3892/etm.2011.30822977592
   PubMed Web of Science ®Google Scholar
• Rice TW, Rusch VW, Ishwaran H, et al. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American joint committee on cancer/international union against cancer staging manuals. Cancer. 2010;116(16):3763–3773. doi:10.1002/cncr.2514620564099
   PubMed Web of Science ®Google Scholar
• Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649–655.7165009
   PubMed Web of Science ®Google Scholar
• Shen LJ, Chen C, Li BF, et al. High weight loss during radiation treatment changes the prognosis in under-/normal weight nasopharyngeal carcinoma patients for the worse: a retrospective analysis of 2433 cases. PLoS One. 2013;8(7):e68660. doi:10.1371/journal.pone.006866023869226
   PubMed Web of Science ®Google Scholar
• Beaver ME, Matheny KE, Roberts DB, et al. Predictors of weight loss during radiation therapy. Otolaryngol Head Neck Surg. 2001;125(6):645–648. doi:10.1067/mhn.2001.12042811743469
   PubMed Web of Science ®Google Scholar
• Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–7259. doi:10.1158/1078-0432.CCR-04-071315534099
   PubMed Web of Science ®Google Scholar
• Van Der Schaaf MK, Tilanus HW, Van Lanschot JJ, et al. The influence of preoperative weight loss on the postoperative course after esophageal cancer resection. J Thorac Cardiovasc Surg. 2014;147(1):490–495. doi:10.1016/j.jtcvs.2013.07.07224060365
   PubMed Web of Science ®Google Scholar
• Skipworth J, Foster J, Raptis D, et al. The effect of preoperative weight loss and body mass index on postoperative outcome in patients with esophagogastric carcinoma. Dis Esophagus. 2009;22(7):559–563. doi:10.1111/j.1442-2050.2009.00939.x19222536
   PubMed Web of Science ®Google Scholar
• Kuo YH, Shi CS, Huang CY, et al. Prognostic significance of unintentional body weight loss in colon cancer patients. Mol Clin Oncol. 2018;8(4):539–543.29564130
   PubMed Web of Science ®Google Scholar
• Unal D, Orhan O, Eroglu C, et al. Prealbumin is a more sensitive marker than albumin to assess the nutritional status in patients undergoing radiotherapy for head and neck cancer. Contemp Oncol (Pozn). 2013;17(3):276–280. doi:10.5114/wo.2013.3528124596514
   PubMed Web of Science ®Google Scholar
• Allum WH, Stenning SP, Bancewicz J, et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27(30):5062–5067. doi:10.1200/JCO.2009.22.208319770374
   PubMed Web of Science ®Google Scholar
• van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–2084. doi:10.1056/NEJMoa111208822646630
   PubMed Web of Science ®Google Scholar
• Mariette C, Dahan L, Mornex F, et al. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. J Clin Oncol. 2014;32(23):2416–2422. doi:10.1200/JCO.2013.53.653224982463
   PubMed Web of Science ®Google Scholar
• Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12(7):681–692. doi:10.1016/S1470-2045(11)70142-521684205
   PubMed Web of Science ®Google Scholar
• Lv J, Cao XF, Zhu B, et al. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterol. 2009;15(39):4962–4968. doi:10.3748/wjg.15.496219842230
   PubMed Web of Science ®Google Scholar
• Ando N, Iizuka T, Ide H, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group study-JCOG9204. J Clin Oncol. 2003;21(24):4592–4596. doi:10.1200/JCO.2003.12.09514673047
   PubMed Web of Science ®Google Scholar
• Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19(1):68–74. doi:10.1245/s10434-011-2049-921879261
   PubMed Web of Science ®Google Scholar
• Zhang SS, Yang H, Xie X, et al. Adjuvant chemotherapy versus surgery alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studies. Dis Esophagus. 2014;27(6):574–584. doi:10.1111/dote.1207323621119
   PubMed Web of Science ®Google Scholar
• Li S, Liu H, Diao C, et al. Prognosis of surgery combined with different adjuvant therapies in esophageal cancer treatment: a network meta-analysis. Oncotarget. 2017;8(22):36339–36353. doi:10.18632/oncotarget.1619328423740
   PubMedGoogle Scholar
• Rawat S, Kumar G, Kakria A, Sharma MK, Chauhan D. Chemoradiotherapy in the management of locally advanced squamous cell carcinama esophagus: is surgical resection required? J Gastrointest Cancer. 2013;44(3):277–284. doi:10.1007/s12029-013-9477-723389866
   PubMedGoogle Scholar